Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05505500 · ClinicalTrials.gov registry record

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

A clinical trial of Edema and Fluid Overload, sponsored by University of Michigan.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT05505500 is a study of Edema and Fluid Overload that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 150 participants, below the 453-participant average among 13 other Edema trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05505500, a study of Edema and Fluid Overload, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing new medications for Nephrotic Syndrome. Please consider participating in a 1-hour long interview with the Prepare-NS research study to discuss children and adults experiences with swelling.

Interventions

  • BEHAVIORAL Interview

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-04-18
Est. Completion 2026-04-30

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05505500

The ClinicalTrials.gov registry entry for NCT05505500 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 13 other Edema trials with a reported enrollment target (67% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Edema appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.

NCT05505500 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05505500 about?

NCT05505500 is a clinical study titled "Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.". Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used...

What is the current status of trial NCT05505500?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-04-18. Estimated completion is 2026-04-30.

What conditions does trial NCT05505500 study?

This clinical trial studies the following conditions: Edema, Fluid Overload, Nephrotic Syndrome, Minimal Change Disease, Membranous Nephropathy.

What interventions are being tested in trial NCT05505500?

The interventions under investigation include: Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT05505500?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05505500 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Edema

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.